Top High Tech Stocks To Invest In Right Now

Dude, these tax-revenue figures are really harshing my mellow.

NEW YORK (CNNMoney) It's been just three months since marijuana was legalized in Colorado, but economists don't think the state will raise as much in taxes as was hoped.

They had expected to raise $22.7 million before July from special sales taxes on recreational marijuana, but state economist Larson Silbaugh is skeptical.

About $3.4 million was raised in January and February, the only months for which sales have been reported so far.

"If current tax revenues keep coming in at the same pace, we won't meet that expectation," Silbaugh said.

Economists have also lowered the forecast for the full fiscal year ending in June 2015 to $54.7 million from $67 million.

Top Solar Stocks To Buy For 2015: Mobile TeleSystems (MBT)

Mobile TeleSystems OJSC, together with its subsidiaries, provides telecommunications services primarily in the Russian Federation, Ukraine, Uzbekistan, Armenia, and Belarus. The company provides a range of mobile and fixed line voice and data telecommunications services, including transmission, broadband, pay-TV, and various value-added services; and sells equipment and accessories. It also offers network access services, including mobile cellular voice and data communication services; automatic roaming services; GPRS and Internet access services; and 3G technology. In addition, the company�s services include the design, construction, and installation of local voice and data networks capable of interconnecting with fixed line operators; installation and maintenance of cellular payphones; lease of digital communication channels; and provision of access to open computer databases and data networks, including the Internet, as well as video conferencing, and fixed, local, and long-distance telecommunications services. Its value-added services comprise call divert/forwarding, caller ID and anti-caller ID display, conference calling, WiFi, GPRS, intelligent call assistant, APN remote access point, fixed mobile convergence, enhanced data rates for GSM Evolution, call barring, SMS, mobile office, voicemail, mobile banking, wireless application protocol, MTS-Connect, SIM-browser, point-to-point transfer, unstructured supplementary services data, downlink packet access, mobile TV, call waiting, MMS, ring tones, missed call alert, itemization of monthly bills, information and directory, international access, WEB and WAP portal, customer care system, ring back tone, collect call, and location-based services. As of December 31, 2011, the company had a mobile subscriber base of approximately 101.14 million. It has a strategic partnership with Vodafone. The company was founded in 1993 and is headquartered in Moscow, the Russian Federation.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  For one thing, Russian telecom firms VimpelCom Ltd. (Nasdaq ADR: VIP) and Mobile TeleSystems OJSC (NYSE ADR: MBT) each do "considerable business" in Ukraine, the trade journal reports. For instance, MTS had about 22.4 million subscribers in that country as of September, making it Ukraine's No. 2 mobile provider, Reuters reported. And VimpelCom gets about 8% of its cash flow from that market.

• [By Jake L'Ecuyer]

  Telecommunications services sector was the leading decliner in the US market today. Telecommunications services stocks dropped 0.43% in today's trading. Among the stocks, Mobile Telesystems OJSC (NYSE: MBT) was down more than 4.8%, while Telecom Argentina SA (NYSE: TEO) tumbled around 2.5%.

Top High Tech Stocks To Invest In Right Now: Axxess Pharma Inc (AXXE)

Axxess Pharma Inc. is a pharmaceutical company. It is engaged in marketing of dermatological, therapeutic nutritionals, pain management, and diagnostic products in Canada and abroad. In October 2013, the Company announced that it has incorporated a wholly owned subsidiary AllStar HealthBrands Inc.

The Company various products include Britical Tablets, Gravergol Capsules, Lactrase Capsules, Somnol Tablets, Triferexx -150 Polysaccharide-iron complex, Urasal Granules, Axspaz Tablets, Vivol Tablets, Hydraxx Lotion, Kemsol Solution, Soropon shampoo, and Skin care Products. Its distribution network includes physicians, hospitals, Government and defense institutions, and pharmacies.

Advisors' Opinion:

• [By Peter Graham]

  Small cap healthcare and lifestyle stocks Axxess Pharma Inc (OTCMKTS: AXXE), Medefile International Inc (OTCMKTS: MDFI) and Intelligent Living Inc (OTCMKTS: ILIV) have all been getting some extra attention lately thanks in part to a few disclosed paid promotions or investor relations type of activities. But just how healthy are these small cap stocks for investors and traders alike? Here is a quick reality check:

  Axxess Pharma Inc (OTCMKTS: AXXE) Has Been Busy With the Press Releases

  Small cap Axxess Pharma is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. On Friday, Axxess Pharma fell 7.52% to $0.295 for a market cap of $12.46 million plus AXXE is down 88.8% over the past year and down 99.8% over the past five years in intermittent trading according to Google Finance.

• [By Peter Graham]

  Small cap health care or personal care stocks Axxess Pharma Inc (OTCMKTS: AXXE), Radiant Creations Group Inc (OTCBB: RCGP) and Tauriga Sciences Inc (OTCMKTS: TAUG) have recently been attracting attention in various investment newsletters or in investor alerts. Some of the attention may have to do with paid promotions that two of these small caps have been the subject of. So how healthy are these three small cap health care or personal care orientated stocks? Here is a checkup:

Top High Tech Stocks To Invest In Right Now: Synageva BioPharma Corp (GEVA)

Synageva BioPharma Corp., incorporated in 1993, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products. It has several protein therapeutics in development, including two enzyme replacement therapies for lysosomal storage disorders and two programs for life-threatening genetic conditions. Its lead program, SBC-102, recombinant human lysosomal acid lipase (LAL), is its advanced pipeline program in clinical development for LAL Deficiency. This enzyme is responsible for the metabolism of cholesteryl esters and triglycerides that are delivered to lysosomes by a variety of routes, including low-density lipoprotein receptor mediated endocytosis. On November 2, 2012, Trimeris, Inc. merged with Synageva BioPharma Corp.

SBC-102 is produced by recombinant deoxyribonucleic acid (DNA) technology in egg white using its protein manufacturing platform. The Company has initiated natural history studies in approximately 20 countries. In addition to SBC-102, it is progressing protein therapeutic programs for other rare diseases, which are at different stages of preclinical development. These include two enzyme replacement therapies for other lysosomal storage disorders and two programs for other rare life-threatening conditions. As of December 31, 2011, its product candidate pipeline included SBC-102, SBC-103, SBC-104, SBC-105 and SBC-106.

SBC-104 is an extracellular protein that targets a severe, rare genetic condition. SBC-105 is an enzyme replacement therapy being developed to treat a severe, rare metabolic disorder. SBC-106 is a protein therapy that targets a severe and rare genetic condition.

Advisors' Opinion:

• [By Garrett Cook]

  Shares of Synageva BioPharma (NASDAQ: GEVA) were down 14.42 percent to $89.69 after the company reported that Phase 3 study met primary endpoint and six secondary endpoints across multiple disease-related abnormalities. Citigroup initiated coverage on Synageva BioPharma with a Neutral rating.

Top High Tech Stocks To Invest In Right Now: Tredegar Corporation(TG)

Tredegar Corporation, through its subsidiaries, manufactures and sells plastic films and aluminum extrusions worldwide. The company offers apertured film and nonwoven materials for use in feminine hygiene products, baby diapers, and adult incontinence products under the SoftQuilt, ComfortAire, SoftAire, and FreshFeel names; breathable, embossed, and elastic materials for use as components for baby diapers, adult incontinence products, and feminine hygiene products under the ExtraFlex, FabriFlex, StretchTab, FlexAire, and FlexFeel names; and absorbent transfer layers for baby diapers and adult incontinence products under the AquiDry and AquiSoft names. It also provides single and multi-layer surface protection films under the UltraMask and ForceField names for protecting components of flat panel displays; a line of packaging films for food packaging and industrial applications; and apertured films, breathable barrier films, and laminates that regulate fluid or vapor transmi ssion. In addition, the company offers soft-alloy aluminum extrusions primarily for building and construction, distribution, transportation, electrical, consumer durables, and machinery and equipment markets; and manufactures mill, anodized, and painted aluminum extrusions for fabricators and distributors to produce curtain walls, storefronts, windows and doors, hurricane shutters, tub and shower enclosures, heatsinks and components for light emitting diode (LED) lighting, and automotive and light truck aftermarket parts. Further, it develops and produces microstructure-based optical films for the LED and fluorescent lighting markets; and develops, owns, and operates mitigation banks. Tredegar Corporation was founded in 1988 and is headquartered in Richmond, Virginia.

Advisors' Opinion:

• [By Bryan Murphy]

  It's certainly not as big as Berry Plastics Group Inc. (NYSE:BERY). It's not even as big as Tredegar Corporation (NYSE:TG). There's one big way AEP Industries (NASDAQ:AEPI) can certainly compete head-on with BERY and TG right now, however... as an investment opportunity. Thanks to the bullish bump AEPI gave us last week, a long-standing selloff has been revered, and there's a whole lot of ground to make up.

Top High Tech Stocks To Invest In Right Now: Comfort Systems USA Inc. (FIX)

Comfort Systems USA, Inc. provides installation, maintenance, repair, and replacement services for the heating, ventilation, and air conditioning (HVAC) systems in the mechanical services industry in the United States. The company engages in the design, engineering, integration, installation, and start-up of HVAC, building automation controls, and related systems; and maintenance, repair, replacement, reconfiguration, and monitoring of HVAC systems and industrial process piping. It also provides specialized applications, such as building automation control systems, fire protection, process cooling, electronic monitoring, and process piping, as well as electrical and plumbing services. The company offers its services for office buildings, retail centers, apartment complexes, and manufacturing plants, as well as healthcare, education, and government facilities. It serves building owners and developers, general contractors, architects, consulting engineers, and property manag ers in the commercial, industrial and institutional HVAC markets. Comfort Systems USA, Inc. was founded in 1917 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Comfort Systems USA (NYSE: FIX  ) , whose recent revenue and earnings are plotted below.

• [By Jeremy Bowman]

  What: Shares of HVAC-service provider Comfort Systems USA (NYSE: FIX  ) were heating up today, gaining as much as 13% on a promising earnings report.

Top High Tech Stocks To Invest In Right Now: ARIAD Pharmaceuticals Inc.(ARIA)

ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company?s lead cancer product, ridaforolimus is being studied in multiple clinical trials in patients with various types of cancers, including metastatic sarcomas, breast cancer, endometrial cancer, prostate cancer, and non-small cell lung cancer. Its product pipeline also includes ponatinib, a pan BCR-ABL inhibitor in phase 2 clinical trial for applications in various hematological cancers and solid tumors; and AP26113, an anaplastic lymphoma kinase inhibitor in preclinical studies for the treatment of various cancers, including non-small cell lung cancer, lymphoma, and neuroblastoma. In addition, the company focuses on a drug discovery program centered on small-molecule therapies that are molecularly targeted to cell-signaling pathways implicated in cancer. Further, it licenses its ARGENT cell-sign aling regulation technologies to pharmaceutical and biotechnology companies to develop and commercialize therapeutic products, and to conduct drug discovery research. The company has collaboration and license agreements with Merck & Co., Inc. for the development, manufacture, and commercialization of ridaforolimus; and license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to deliver ridaforolimus to prevent restenosis of injured vessels. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is based in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Luke Jacobi]

  Ariad Pharmaceuticals (NASDAQ: ARIA) tumbled 40.67 percent to $2.67 after the company announced discontinuation of the Phase 3 EPIC trial of Iclusig.